Xconomy.com -- Shire an Ireland-based drug company that has its Human Genetic Therapies unit based in Cambridge, MA—reports that it has asked European regulators to approve its treatment for Gaucher disease, velaglucerase alfa.
Xconomy.com -- Shire an Ireland-based drug company that has its Human Genetic Therapies unit based in Cambridge, MA—reports that it has asked European regulators to approve its treatment for Gaucher disease, velaglucerase alfa.
